Clinical trial
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain…
NCT00430196 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00430196 |
|---|---|
| Title | BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity |
| Official title | Placebo-Controlled Trial of BOTOX® Versus Zanaflex® for the Treatment of Subjects With Post Stroke Upper Limb Spasticity |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Upper Limb Spasticity |
| Intervention type | Drug |
| Interventions | BOTOX®, Zanaflex® |
| Enrollment | 135 |
| Start date | Dec 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Feb 1, 2007 |
| Last update posted | Feb 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: